Two probes better than one? new study aims to cut cervical cancer in women with HIV
NCT ID NCT07390916
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether using two heat probes instead of one to treat cervical precancer works better for women living with HIV. Researchers in Rwanda will enroll 300 women to see if the two-probe approach is safe, acceptable, and more effective at clearing HPV. The goal is to improve cervical cancer prevention in high-risk groups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
thermal ablation (heat treatment to remove precancerous cells)
What this could lead to
If successful, this could improve cervical cancer prevention for women with HIV, potentially reducing cancer rates in high-risk populations.
What could go wrong
This is a small feasibility study, not yet recruiting. The two-probe technique may not work better than the standard one-probe approach, and results may not apply to other groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV - HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research for Development (RD) Rwanda
Kigali, Rwanda
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact